ArticleBritish journal of clinical pharmacology2025

Adverse drug reactions, particularly liver disorders, drive interruptions in anti-tuberculosis treatment: A retrospective cohort study.

Eleanor G Dixon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.